Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FAS receptor (also known as Fas, APO-1, CD95, or TNFRSF6) is a cell surface death receptor that plays a central role in regulating programmed cell death (apoptosis), particularly within the immune system. Upon binding its ligand, FasL, it triggers a cascade of events leading to apoptosis. The Fas/FasL system has critical roles in immune homeostasis, terminating immune responses, and preventing autoimmunity and tumor development. Alterations or mutations affecting FAS function have been linked with autoimmune diseases and certain cancers.
Binding of Fas ligand (FasL) induces receptor trimerization, recruitment of adaptor proteins (FADD), formation of the Death-Inducing Signaling Complex (DISC), and activation of caspases leading to apoptosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FAS receptor (FasR).